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ORIGINAL ARTICLE
Abstract
Objective: To evaluate the lung function and clinical outcome 
in severe chronic obstructive pulmonary disease in patients 
undergoing off-pump coronary artery bypass grafting with 
left internal thoracic artery graft, comparing the pleural drain 
insertion in the intercostal versus subxyphoid region. 
Methods: A randomized controlled trial.  Chronic 
obstructive pulmonary disease patients were randomized 
into two groups according pleural drain site: II group (n=27) 
- pleural drain in intercostal space; SI group (n=29) - pleural 
drain in the subxyphoid region. Spirometry values (Forced 
Vital Capacity - and Forced expiratory volume in 1 second) 
were obtained on preoperative and 1, 3 and 5 postoperative 
days. Chest x-ray from preoperative until postoperative day 
5 (POD5) was performed for monitoring respiratory events, 
such as atelectasis and pleural effusion. Pulmonary shunt 
fraction and pain score was evaluate preoperatively and on 
postoperative day 1. 
Results: In both groups there was a significant decrease of the 
spirometry values (Forced Vital Capacity and Forced expiratory 
volume in 1 second) until POD5 (P<0.05). However, when 
compared, SI group presented less decrease in these parameters 
(P<0.05). Pulmonary shunt fraction was significantly lower in 
SI group (P<0.05). Respiratory events, pain score, orotracheal 
intubation time and postoperative length of hospital stay were 
lower in the SI group (P<0.05). 
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function[6,7]. Our hypothesis is that reducing thoracic trauma 
in COPD patients underwent OPCAB could determine lower 
impairment to the lung function and better clinical results.
Therefore, the aim of this study was to evaluate the pul-
monary function and clinical outcomes in severe COPD pa-
tients, comparing pleural drain insertion site in intercostal 
space versus subxyphoid region after OPCAB using left ITA 
(LITA).
METHODS
This prospective randomized study was performed be-
tween December 2007 and March 2012 at the Cardiovascular 
Surgery Discipline, Sao Paulo and Pirajussara Hospitals of 
the Federal University of Sao Paulo, Sao Paulo, Brazil. The 
Institutional Human Ethics Committee approved the protocol 
and written informed consent was obtained from all patients.
Patients study group
Patients of both sexes, age between 35 and 75 years old, 
coronary disease confirmed by coronary angiography, under-
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) has been 
associated with increased morbidity and mortality in patients 
undergoing coronary artery bypass graft (CABG)[1]. Many 
studies showed that as higher severity degree of COPD is 
associated to longer mechanical ventilation time and length 
of stay in the hospital and, consequently, increased hospi-
tal costs[2]. Furthermore, severe COPD patients undergoing 
CABG have a worse prognosis and increased mortality rate 
at long-term, when compared to patients without COPD[3,4].
Several factors may influence pulmonary function and 
clinical results in patients undergoing CABG, such as: gen-
eral anesthesia, sternotomy, cardiopulmonary bypass, inter-
nal thoracic artery (ITA) graft with pleurotomy and pleural 
drain[5]. Pleural drain insertion through intercostal space 
promotes higher thoracic trauma, increased pain and discom-
fort for the patient, leading to increased vulnerability to lung 
complications. In patients without COPD undergoing off- 
pump CABG (OPCAB), the shift of pleural drain insertion 
to subxyphoid region reduces postoperative pulmonary dys-
Conclusion: Subxyphoid pleural drainage in severe Chronic 
obstructive pulmonary disease patients determined better 
preservation and recovery of pulmonary capacity and volumes 
with lower pulmonary shunt fraction and better clinical outcomes 
on early postoperative off-pump coronary artery bypass grafting.
Descriptors: Pulmonary Disease, Chronic Obstructive. 
Respiratory Function Tests. Coronary Artery Bypass, Off-Pump.
Resumo
Objetivo: Avaliar a função pulmonar e os resultados clínicos 
em pacientes com doença pulmonar obstrutiva crônica grave 
submetidos à cirurgia de revascularização do miocárdio sem 
circulação extracorpórea, com enxerto da artéria torácica interna 
esquerda, comparando a inserção do dreno pleural intercostal 
versus subxifoide.
Métodos: Estudo clínico, controlado e randomizado. Pacientes 
com doença pulmonar obstrutiva crônica foram randomizados 
em dois grupos de acordo com a posição do dreno pleural: 
grupo II (n=27) - dreno pleural intercostal; grupo IS (n=29) - 
dreno pleural na região subxifóide. Os valores espirométricos 
(Capacidade Vital Forçada e Volume expiratório forçado no 1 
segundo) foram obtidos no pré-operatório, e no 1º, 3º e 5º dias 
de pós-operatório. Foi realizada radiografia de tórax no pré-
operatório até o 5º dia pós-operatório (5PO) para monitoração 
de eventos respiratórios, como atelectasia e derrame pleural. A 
fração de shunt pulmonar e a escala de dor foram avaliadas no 
1º dia pós-operatório. 
Resultados: Em ambos os grupos houve queda significativa 
dos valores espirométricos (Capacidade Vital Forçada e Volume 
expiratório forçado no 1 segundo) até o 5PO (P<0.05), porém, 
quando comparados, o grupo IS apresentou menor queda 
destes parâmetros (P<0.05). A fração de shunt pulmonar foi 
significativamente menor no grupo IS (P<0.05). Os eventos 
respiratórios, escala da dor, tempo de intubação orotraqueal e 
dias internação hospitalar no pós-operatório foram menores no 
grupo IS (P<0.05). 
Conclusão: Drenagem pleural subxifoide em pacientes 
com doença pulmonar obstrutiva crônica grave determinou 
melhor preservação e recuperação dos volumes e capacidades 
pulmonares, com menor fração de shunt pulmonar e melhores 
resultados clínicos no pós-operatório precoce de cirurgia de 
revascularização do miocárdio sem circulação extracorpórea.
Descritores: Doença Pulmonar Obstrutiva Crônica. Testes 
de Função Respiratória. Ponte de Artéria Coronária sem 
Circulação Extracorpórea.
Abbreviations, acronyms & symbols
CABG Coronary artery bypass graft 
COPD Chronic obstructive pulmonary disease 
FEV1 Forced expiratory volume in 1 second  
FVC Forced Vital Capacity 
ITA Internal thoracic artery 
OPCAB Off-pump coronary artery bypass grafting
POD Postoperative day 
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going elective OPCAB using LITA, with an ejection fraction 
> 50%, and severe COPD were included in this study. We 
excluded patients unable to perform spirometry, with hemo-
dynamic instability, intraoperative death, renal failure (cre-
atinine >1.3 mg/dL), intact pleura, intraoperative complica-
tions requiring on-pump CABG conversion and patients who 
required additional analgesia.
The subjects were randomized into two groups by com-
puterized system according to pleural drain position and the 
secrecy was maintained by sealed, numbered and opaque en-
velopes: II group (n=27), pleural drain was inserted in the 
sixth intercostals space; and SI group (n=29), pleural drain in 
the subxyphoid position.
Lung function assessment
Spirometry records were obtained to evaluate the forced 
vital capacity (FVC) and the forced expiratory volume in 1 
second (FEV1) on preoperative and postoperative days 1, 3, 
and 5 (POD1, POD3, POD5) by the same respiratory phys-
iotherapist, using a portable espirometer (Spirobank G, MIR, 
Rome, Italy) according to the standards of the American Tho-
racic Society[8]. Chronic obstructive pulmonary disease was 
defined according to the criteria of the Global Initiative for 
Chronic Obstructive Lung Disease – GOLD, with presence 
of dyspnea (progressive and/or persistent), chronic cough 
or sputum production, and/or a history of exposure to risk 
factors for the disease (tobacco smoking, occupational dusts 
and chemical), and by spirometry with FEV1/FVC < 0.70. 
Furthermore, the severity of COPD was defined as described 
on Table 1[9].
Anesthesia and ventilation management
All patients received a standard anesthetic technique, 
induction with etomidate and midazolam, maintenance 
with sufentanil and isofluorane (0.5% to 1%) and were me-
chanically ventilated to maintain normocapnia, with a 50% 
inspired oxygen fraction without positive end-expiratory 
pressure. Intraoperative fluids were given according to the 
anesthetist discretion.
Operative technique
The OPCAB surgery was performed through a median 
sternotomy, using LITA complemented with additional saphe-
nous vein grafts. The LITA was harvested in a skeletonized 
fashion. A heated water mattress was used to keep all patients 
normothermic throughout the operation. OPCAB has followed 
the pattern at our service. Briefly, with systemic heparinization 
to achieve an activated clotting time exceeding 250 seconds, 
occlusion of the coronary artery was accomplished by using 
a proximal soft silicone snare. The distal anastomosis was 
accomplished with a 7-0 running polypropylene suture. The 
vein top ends were then attached to the ascending aorta using 
side-bite clamping. An Octopus 3 (Medtronic, Inc, Minneapo-
lis, MN) suction stabilizer was used in all cases. Before chest 
closure, and in the presence of left pleura opening, the site of 
pleural drain insertion was randomized. A soft tubular straight 
PVC drain (¼ inch) was inserted and exteriorized at the inter-
section of the sixth left intercostal space (Group II) or a curved 
one at the subxyphoid region and positioned in the left costo-
phrenic sinus (Group SI). In all patients, a straight mediastinal 
drain was also placed via a subxyphoid approach.
Postoperative Management
All patients were transferred to the intensive care unit 
(ICU) with orotracheal intubation, inspired oxygen fraction 
to keep arterial oxygen saturation above 90%, predicted tidal 
volume of 8 ml/kg, PEEP of 5 cmH2O and extubated accord-
ing to ICU protocol. The drains (mediastinal and/or pleural) 
were routinely removed on POD2.
During postoperative days, the patients were evaluated by 
the same physiotherapist and all patients were undergone to 
the same physical therapy program until hospital discharge 
(breathing exercises and early deambulation).
Clinical Outcomes
All patients underwent to the same analgesic protocol 
administered during the postoperative period (100mg of tra-
madol chlorhydrate 4 times a day). Pain was evaluated and 
quantified by Visual Analogical Scale (VAS)[10] (0 = no pain 
to 10 = unbearable pain) on POD1 and before spirometry. 
Total orotracheal intubation time and length of hospital stay 
after surgery were also recorded.
The patients were undergoing chest radiography on pre-
operative, POD1, POD3 and POD5 for monitoring respira-
Table 1. Chronic obstructive pulmonary disease stage classification 
according to GOLD Guidelines.
Stage I: 
mild COPD
Stage II: 
moderate COPD
Stage III: 
severe COPD
Stage IV: 
very severe COPD
FEV1/CVF < 70% andFEV1 ≥ 80%
FEV1/CVF < 70% and 50% ≤ FEV1< 80%
FEV1/CVF < 70% and 30% ≤ FEV1< 50%
FEV1/CVF < 70% and FEV1< 30%
COPD = Chronic obstructive pulmonary disease; FEV1=Forced 
expiratory volume in 1 second; FVC=forced vital capacity; 
GOLD =Global Initiative for Chronic Obstructive Lung Disease
Pulmonary shunt fraction was evaluated preoperatively 
and on POD1 using the software Oxygen Status Algorithm, 
(version 2.0; Mads & Ole Siggaard; Radiometer). This soft-
ware needs the arterial blood gas and the fraction of inspired 
oxygen to calculate the percentage of blood that is not sup-
plied by oxygen.
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tory events, like pleural effusion and atelectasis. The radio-
logical evaluation was performed by the same radiologist, 
blinded to the study. The pleural effusion was deemed sig-
nificant when exceeding the costophrenic angle. Atelectasis 
was acknowledged when a clear atelectasis radiologic shad-
ow exceeded 15 mm in width, with linear atelectasis being 
disregarded in this study.
 
Statistical analysis
Data were expressed as mean ± standard deviation. The 
FVC, FEV1 were analyzed, and values are expressed as a 
percentage of the preoperative value considered as 100% 
the preoperative baseline value. Intragroup variables com-
paring pre versus postoperative values were evaluated by 
paired Student t tests and analysis of variance for repeated 
measures with the Newman-Keuls posttest. Differences be-
tween groups were analyzed by unpaired Student t test or the 
Mann-Whitney test, when necessary. The categoric data were 
analyzed by the Pearson chi-square test. Statistical analysis 
was performed with GraphPad Prism 3.0 software (Graph-
Pad Software Inc, San Diego, CA). A value of P<0.05 was 
considered statistically significant.
RESULTS
Initially, 165 subjects were selected for this study, how-
ever, 95 were excluded in the pre- and intraoperative, 14 
were lost to follow-up and 56 were actually analyzed ac-
cording to Figure 1. Groups were homogeneous preoper-
atively in terms of age, gender, body mass index (BMI), 
preoperative pulmonary function, operative time, number 
of grafts per patients with no significant statistically differ-
ences, as shown in Table 2.
No signs of preoperative myocardial infarction were de-
tected in either group, as assessed by electrocardiographic 
changes or enzyme elevation.
In the postoperative period, the both groups presented 
significant reduction in spirometric parameters (FVC and 
FEV1) until POD5 (P<0.05). However, when compared the 
values, the SI group presented lower impairment (Figure 2).
The pulmonary shunt fraction increase in both groups, 
but was significantly lesser in SI group (0.24±0.03% versus 
0.28±0.04%; P<0.001).
In relation to respiratory events, lower incidence of atel-
ectasis and pleural effusion was observed in SI group (atelec-
tasis: 21±3.4% versus 25±0.1%; P=0.001 e pleural effusion: 
22±2.4% versus 26±1.7%; P=0.003).
The chest pain sensation was lesser in group SI than II 
group (4.6±3.4 versus 7.9±2.1, P=0.001). Moreover, the time 
of mechanical ventilation and the length of hospital stay was 
lower in SI group when compared to II group (13.98±1.4 
hours versus 16.25±2.1 hours; P=0.001; 9.51±1.6 days ver-
sus 12.1±1.4 days; P<0.001).
Fig. 1 - Flow diagram of the progress through the phases of a 
randomized trial.
Table 2. Baseline patient characteristics.
Variables
Age (years)
Gender (n)
Male/ Female
BMI (kg/m2)
Pulmonary function
FVC (L)  
% predicted 
FEV1 (L) 
% predicted 
Pulmonary shunt
fraction (%)
Surgery time (min)
Grafts per patient (n) 
Group II 
(N=27) 
59.22 ± 11.73 
18/9
24.52 ± 3.56 
3.27 ± 0.26 
98.2 ± 21.70
1.40 ± 0.35
40.32 ± 7.22
0.03 ± 0.03
314.8 ± 29.78
2.71 ± 0.42
Group SI 
(N=29) 
56.66 ± 10.33 
20/9
26.12± 4.61 
3.51± 0.45 
101.25 ± 25.24
1.37 ± 0.22
38.21 ± 9.07
0.04 ± 0.02
309.4 ± 21.98
2.62 ± 0.77
P
0.32
0.42
0.24
0.39
0.32
0.10
0.33
0.39
Data are shown as mean ± standard deviation. BMI = body mass 
index; FEV1 = Forced expiratory volume in 1 second; FVC = forced 
vital capacity; II = intercostal insertion; SI = subxyphoid insertion.
DISCUSSION
The results demonstrated that both groups presented im-
pairment in pulmonary function in the early postoperative. 
However, the patients of SI group presented better pulmo-
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nary function and clinical outcomes when compared to II 
group. This data corroborate with findings by other studies 
with patients without COPD[5,11].
tensity[6,7,11]. Furthermore, Guizilini et al.[19] observed that the 
insertion of a chest tube in the subxyphoid region resulted in 
similar findings to CABG with intact pleura.
COPD can also be considered a risk factor for develop-
ment of pulmonary dysfunction in postoperative period of 
CABG. Fuster et al.[2] and Lizak et al.[20] compared postop-
erative outcomes of patients with and without COPD and 
observed that patients with COPD had a higher incidence 
of pulmonary complications and hospital stay, more pro-
nounced in patients with severe COPD.
Taking into account evidence that shifting the site of drain 
insertion to the subxyphoid region may be beneficial for the 
postoperative clinical outcomes, and the fact that patients 
with severe COPD have a higher risk of pulmonary compli-
cations in this period, this study aimed to answer the follow-
ing question: Do patients with clinically severe COPD would 
benefit by shifting the drain position in the postoperative pe-
riod of OPCAB using the LITA graft? For our knowledge, no 
randomized controlled trial has evaluated the impact of drain 
shifting in severe COPD patients undergoing OPCAB, which 
makes our proposal innovative and original.
Previous studies compared the effectiveness of shifting 
the drain insertion site to the subxyphoid region and reported 
lesser lung function impairment[6,11,19]. These findings corrob-
orate the results found in this study, reiterating the hypothesis 
that subxyphoid drain minimizes the dysfunction in postop-
erative period of OPCAB surgery, even in patients with se-
vere COPD.
Regarding the chest pain, patients with subxyphoid drain 
reported less intensity on VAS. The same result was reported 
in other studies with patients without COPD, which showed 
less pain when the chest tube was inserted in the subxyphoid 
region[6,11,21]. Similar outcomes were found in this study.
Sensoz et al.[11] evaluated patients with COPD undergo-
ing on-pump CABG by means of computed tomography. 
Patients who belonged to the group with pleural drain in 
subxyphoid region evolved with a lower incidence of at-
electasis in postoperative period, corroborating the results 
found in this study.
Hypoxemia is also an unavoidable consequence in CABG 
postoperative, regardless of surgical technique[5,6]. There are 
many causes of hypoxemia, abnormal diffusion, hypoventi-
lation and shunt. In this study, the pulmonary shunt fraction 
was assessed on the first postoperative day, which was sig-
nificantly lower in the subxyphoid group.
These findings could be explained due to better preserva-
tion and recovery of FVC and consequently decrease of pul-
monary fraction shunt, reflects the chest wall lesser degree of 
trauma in patients with pleural subxyphoid drain.
Fuster et al.[2] associated severe COPD with higher in-
cidence of pneumonia, sepsis and respiratory distress syn-
drome, longer ICU stay, and greater number of hospitalization 
days in the postoperative period of coronary revasculariza-
Fig. 2 - Pulmonary function test values on the POD1, 3 and 5, in 
percentage considering 100% preoperative baseline value. 
Data are shown as mean ± standard deviation. BMI=body mass 
index; FEV1=Forced expiratory volume in 1 second; FVC=forced vital 
capacity; II=intercostal insertion; SI=subxyphoid insertion.
The lung dysfunction in postoperative period after CABG 
is associated with intraoperative procedures. The use of general 
anesthesia[12], the sternotomy[13], cardiopulmonary bypass[5], ITA 
graft with consequent pleurotomy and necessity of pleural drain 
insertion make the pulmonary dysfunction unavoidable[14].
The use of ITA graft for coronary revascularization is as-
sociated with higher survival and less incidence of cardiovas-
cular events when compared to saphenous vein graft[15]. The 
technique of skeletonized ITA dissection has been proved 
beneficial to reduce sternal complications or infections, due 
to better preservation of arterial branches supplying sternal 
and intercostal muscles[16]. Beyond reduction of blood sup-
ply, the manipulation of ITA may lead the opening of pa-
rietal pleura[17]. Consequently to pleurotomy, pleural drain-
age becomes mandatory. In the majority of the operations, 
the chest tube is inserted and exteriorized in the intercostal 
space, coming into contact with the periosteum and the pa-
rietal pleura, which are highly sensitive. Therefore, the use 
of intercostal chest tube can promote ventilatory-dependent 
pain, limiting deep inspiration, which leads to the adoption 
of an antalgic posture, immobilization and reduced lung vol-
umes and capacities[18].
Recent studies have evaluated the postoperative clinical 
follow-up of patients undergoing CABG, with exterioriza-
tion of the drain in the subxyphoid region, and concluded that 
this strategy minimizes the pulmonary dysfunction in post-
operative period, with better spirometric parameters , lower 
rate of atelectasis and pleural effusion, and lower pain in-
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